Every earnings call for NEOGEN — management tone, guidance, KPIs and promise tracking, quarter by quarter.
NEOGEN · 7 transcripts · Chemicals · latest Q4 FY26Revenue (Q4 FY26) ₹247 cr (+22% YoY); EBITDA (Q4 FY26) ₹44 cr (+21% YoY); EBITDA Margin (Q4 FY26) 17.8%. Q4 FY26 consolidated revenue grew 22% YoY to INR 247 crore.
Read full transcript & analysisRevenue ₹220 cr (+9% YoY); EBITDA ₹32 cr; PAT ₹4 cr. Revenue grew 9% YoY to INR 220 crore.
Read full transcript & analysisRevenue ₹209 cr (+8% YoY); EBITDA ₹30 cr; PAT ₹3 cr. Revenue of ₹209 crore, up 8% YoY.
Read full transcript & analysisRevenue ₹187 cr (+4% YoY); EBITDA ₹32 cr (+2% YoY); Consolidated EBITDA Margin 16.9%. Revenue for Q1 FY26 stood at INR 186.7 crore, a 4% increase YoY, despite the Dahej plant's unavailability.
Read full transcript & analysisFY25 Revenue ₹778 cr (+13% YoY); FY25 EBITDA ₹136 cr (+24% YoY); FY25 EBITDA Margin 17.5%. FY25 Revenue stood at ₹778 crores, marking a 13% YoY growth.
Read full transcript & analysisRevenue ₹201 cr (+22% YoY); EBITDA ₹35 cr (+71% YoY); EBITDA Margin 17.2%. Revenue grew 22% YoY to ₹201 crores.
Read full transcript & analysisRevenue ₹193 cr (+20% YoY); EBITDA ₹35 cr (+33% YoY); EBITDA Margin 17.9%. Consolidated revenue grew 20% YoY to Rs. 193 crore.
Read full transcript & analysis